ASCIA Education Projects

Anaphylaxis | Food Allergy | Respiratory/Insect Allergy  | Drug Allergy | Skin/Allergy | Immunodeficiency | Testing | COVID-19   

The ASCIA team works with ASCIA committees and working parties to review, update and develop accessible, consistent and evidence based resources, education and training, to support ASCIA members, other health professionals, patients, carers and the community. 

 ASCIA Anaphylaxis Resources 

The following resources have been developed and/or updated in 2021.

Action Plans, Forms and Checklists

ASCIA Action Plans (5 versions) and First Aid Plans (3 versions) Updated June 2021

ASCIA Action Plan FAQs Updated June 2021
 
ASCIA First Aid Plan for Anaphylaxis - Pictorial New August 2021
 
ASCIA First Aid Plan for Anaphylaxis (with ReadSpeaker) Updated June 2021

ASCIA Travel Plan Updated June Updated June 2021
 
Signs and Symptoms of Allergic Reactions New February 2021
 
Positioning and Anaphylaxis - animation New March 2021

Anaphylaxis Checklist for Adrenaline Prescribers Updated September 2021
 
Anaphylaxis Checklist for Pharmacists Updated September 2021
 
Anaphylaxis Checklist for Patients Updated September 2021
 
Anaphylaxis Checklist for Transitioning from Paediatric to Adult Care Updated September  2021
 
Anaphylaxis Checklist for Travelling with Allergy, Asthma or Anaphylaxis Updated September 2021
 
Adrenaline Injector Information
 
Adrenaline Injector Instructions - How to give EpiPen Updated July 2021
 
Adrenaline Injector Instructions - How to give Anapen Updated July 2021

Adrenaline Injectors for General Use Updated September 2021
 
Adrenaline Injector Supply Updates Updated September 2021

Adrenaline Injectors FAQ Updated September 2021

Adrenaline Injector Storage, Expiry, Disposal Updated September 2021

Adrenaline Injector Prescription Guidelines Updated September 2021
 
Information for Patients, Consumers and Carers 

Adrenaline for Treatment of Anaphylaxis Patient Information Updated September 2021
 

Anaphylaxis Patient Information - English Updated September 2021

Guidelines for Health Professionals

Anaphylaxis Guidelines - Health Professionals Updated July 2021

ASCIA Anaphylaxis e-Training Courses

Anaphylaxis e-training - Refresher New July 2021 
 
Anaphylaxis e-training - Schools and Childrens Education/Care (6 versions) Updated September 2021 
 
Anaphylaxis e-training - Community Updated September 2021

Anaphylaxis e-training - Health Professionals Updated September 2021
 

ASCIA Anaphylaxis e-training - Pharmacists Updated September 2021

The following projects are scheduled to be completed in 2021:

  • New ASCIA Anaphylaxis Refresher e-training for health professionals
  • Updated ASCIA Adrenaline Injectors FAQ

ASCIA Food Allergy Resources 

The following resources have been developed and/or updated in 2021.

Information for Patients, Consumers and Carers - Food Allergy

Food Allergy FAQ Updated May 2021

Oral Immunotherapy (OIT) for Food Allergy FAQ New April 2021

ASCIA Dietary Avoidance for Food Allergy FAQ New May 2021 

ASCIA Dietary Guide for Cow's Milk and Soy Allergy New May 2021

Information for Patients, Consumers and Carers - Other Adverse Reactions to Foods

Oral Allergy Syndrome FAQ New September 2021

Sulfite Sensitivity FAQ Updated July 2021

Eosinophilic Oesophagitis (EoE) FAQ New July 2021

Eosinophilic Oesophagitis (EoE) Dietary Guide - 2FED New July 2021

Eosinophilic Oesophagitis (EoE) Dietary Guide - 4FED New July 2021

Action and Management Plans

Eosinophilic Oesophagitis (EoE) Action Plan New July 2021

Eosinophilic Oesophagitis (EoE) Management Plan New July 2021

Information for Health Professionals

ASCIA Position Paper - Oral Immunotherapy for Food Allergy New April 2021

ASCIA Position Statement - Packaged Foods for Infants that Contain Most of the Common Food Allergens New April 2021

The following projects are scheduled to be completed in 2021:

ASCIA Respiratory and Insect Allergy Resources 

The following resources have been developed and/or updated in 2021. 

ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated May 2021

ASCIA Treatment Plan - Sublingual Immunotherapy (SLIT) New June 2021

How to Safely Remove Ticks animation New  June 2021

The following projects are scheduled to be completed in 2021:

ASCIA Drug (Medication) Allergy Resources 

The following resources have been developed and/or updated in 2021.

ASCIA Action Plan for Drug (Medication) Allergy Updated June 2021

ASCIA Record for Drug (Medication) Allergy Updated June 2021

ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) New July 2021

ASCIA Skin/Allergy Resources 

The following resources have been developed and/or updated in 2021. 

Eczema (Atopic Dermatitis) FAQ Updated August 2021

ASCIA Action Plan for Eczema Updated August 2021

ASCIA Stepwise Management Plan for Eczema Updated August 2021

The following project is scheduled to be completed in 2021:

ASCIA Immunodeficiency Resources 

The following resources have been developed and/or updated in 2021. 

Information for Patients, Consumers and Carers

Common Variable Immunodeficiency (CVID) Updated October 2021

COVID-19 and Immunodeficiency FAQ Updated October 2021
 
Hereditary Angioedema (HAE) FAQ New October 2021

Immunoglobulin Replacement Therapy (IRT) Updated October 2021

Primary Immunodeficiency (Inborn Errors of Immunity) Updated October 2021

Severe Combined Immunodeficiency (SCID) Updated October 2021

Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021

Information for Health Professionals

ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in PID/IEI New September 2021

The following projects are scheduled to be completed in 2021-2022:

ASCIA Testing Resources 

The following resources have been developed and/or updated in 2021. 
 
Information for Patients, Consumers and Carers
 
Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments FAQ New March 2021
  
Information for Health Professionals 
 

ASCIA Position Paper - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021

References - Evidence-Based Versus Non Evidence-Based Allergy Tests and Treatments New March 2021

ASCIA COVID-19 Resources 

The following resources have been developed and/or updated in 2021.

Information for Patients, Consumers and Carers 

Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Frequently Asked Questions (FAQ) for patients, consumers and carers Updated October 2021

COVID-19 and Immunodeficiency Updated October 2021

Checklist - Actions to Reduce the Spread of COVID-19 Updated October 2021

Information for Health Professionals  

COVID-19 Vaccination Guidelines for Clinical Immunology/Allergy Specialists Updated September 2021

Allergy, Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Position Statement for health professionals Updated September 2021

Allergy and COVID-19 Vaccination - Guide for health professionals Updated September 2021

Immunodeficiency, Autoimmunity and COVID-19 Vaccination - Guide for health professionals Updated September 2021 
 

Improving Access to ASCIA information

ReadSpeaker is available on the ASCIA webpages (html, not pdfs) for patients, consumers and carers, to improve access for people with:
  • Vision impairment, limited reading ability or learning disabilities, by allowing text to speech (TTS).
  • Non-English speaking backgrounds - information can be translated into 20 different languages by highlighting the text and selecting 'translate’.
 
Content updated November 2021